The BD Liverty™ TIPS Stent Graft Study (NCT05711316)
The BD Liverty™ TIPS Stent Graft Study - A Global, Prospective, Multi-Center, Single-Arm Clinical Study for the Treatment of Complications From Portal Hypertension
🩺 Plain-English Summary (8th-Grade Level)
The objective of the study is to assess the safety and effectiveness of the BD Liverty™ TIPS Stent Graft for the treatment of the complications of portal hypertension from cirrhosis. This includes recurrent or refractory ascites, hepatic hydrothorax, and/or variceal bleeding (esophageal and/or gastric).
Who can join: Review the eligibility criteria below.
Location: Stanford University — Palo Alto, California
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (26 Sites)
Showing the first 25 of 26 sites.
- Stanford University — Palo Alto, California
- Georgetown University — Washington D.C., District of Columbia
- Trustees of Indiana University ("IU")/ Indiana University Health, Inc. — Indianapolis, Indiana
- University of Kansas Medical Center Research Institute, Inc. — Kansas City, Kansas
- The General Hospital Corporation d/b/a Massachusetts General Hospital — Boston, Massachusetts
- Beth Israel Deaconess Medical Center, Inc. — Boston, Massachusetts
- Washington University - Mallinckrodt Institute of Radiology — St Louis, Missouri
- Rutgers, The State University of New Jersey — Newark, New Jersey
- Icahn School of Medicine at Mount Sinai — New York, New York
- The Trustees of Columbia University in the City of New York — New York, New York
- Charlotte Radiology — Charlotte, North Carolina
- Cleveland Clinic Foundation — Cleveland, Ohio
- University of Pennsylvania — Philadelphia, Pennsylvania
- The University of Texas Health Science Center at San Antonio — San Antonio, Texas
- University of Utah — Salt Lake City, Utah
- University of Virginia — Charlottesville, Virginia
- Medical College of Wisconsin / Froedtert Hospital — Milwaukee, Wisconsin
- Centre Hospitalier Regional Universitaire de Tours — Chambray-lès-Tours,
- CHU Dijon Bourgogne — Dijon,
- Hospices Civils de Lyon — Lyon,
- Charité-Universitätsmedizin Berlin — Berlin,
- Universitätsklinikum Bonn — Bonn,
- Universitatsklinikum Carl Gustav Carus Dresden — Dresden,
- University Hospital Frankfurt — Frankfurt,
- Medizinische Hochschule Hannover — Hanover,
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Portal Hypertension
Explore by condition: All Portal Hypertension clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.